Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avraham Eisbruch

Showing results (131-140 of 256) with videos related to

Pageof 26
Sort By:
Head & Neck|October 9, 2015
Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trialShuang G Zhao, Neil B Alexander, Zora Djuric, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)Avraham Eisbruch, Jonathan Harris, Adam S Garden, et al.
Head & Neck|August 20, 2013
Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancerWilliam M Mendenhall, Anthony A Mancuso, Primoz Strojan, et al.
Oral Oncology|January 19, 2016
Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiationStuart E Samuels, Yebin Tao, Teresa Lyden, et al.
The Laryngoscope|June 28, 2016
Classification of TP53 mutations and HPV predict survival in advanced larynx cancerAdam Scheel, Emily Bellile, Jonathan B McHugh, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 5, 2015
Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation?Andrés Coca-Pelaz, Kenneth O Devaney, Juan P Rodrigo, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patientsAntonetta C Houweling, Marielle E P Philippens, Tim Dijkema, et al.
The Laryngoscope|August 13, 2002
Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancerGregory T Wolf, Carol R Bradford, Susan Urba, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2009
Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancerJoseph K Salama, Robert I Haddad, Merril S Kies, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Parotid gland function after radiotherapy: the combined michigan and utrecht experienceTim Dijkema, Cornelis P J Raaijmakers, Randall K Ten Haken, et al.
Pageof 26

Showing results (131-140 of 256) with videos related to

Sort By:
Pageof 26
Head & Neck|October 9, 2015
Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trialShuang G Zhao, Neil B Alexander, Zora Djuric, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)Avraham Eisbruch, Jonathan Harris, Adam S Garden, et al.
Head & Neck|August 20, 2013
Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancerWilliam M Mendenhall, Anthony A Mancuso, Primoz Strojan, et al.
Oral Oncology|January 19, 2016
Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiationStuart E Samuels, Yebin Tao, Teresa Lyden, et al.
The Laryngoscope|June 28, 2016
Classification of TP53 mutations and HPV predict survival in advanced larynx cancerAdam Scheel, Emily Bellile, Jonathan B McHugh, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 5, 2015
Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation?Andrés Coca-Pelaz, Kenneth O Devaney, Juan P Rodrigo, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patientsAntonetta C Houweling, Marielle E P Philippens, Tim Dijkema, et al.
The Laryngoscope|August 13, 2002
Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancerGregory T Wolf, Carol R Bradford, Susan Urba, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2009
Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancerJoseph K Salama, Robert I Haddad, Merril S Kies, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Parotid gland function after radiotherapy: the combined michigan and utrecht experienceTim Dijkema, Cornelis P J Raaijmakers, Randall K Ten Haken, et al.
Pageof 26